1. Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077. (24th May 2019) Authors: Landovitz, Raphael J; Zangeneh, Sahar Z; Chau, Gordon; Grinsztejn, Beatriz; Eron, Joseph J; Dawood, Halima; Magnus, Manya; Liu, Albert Y; Panchia, Ravindre; Hosseinipour, Mina C; Kofron, Ryan; Margolis, David A; Rinehart, Alex; Adeyeye, Adeola; Burns, David; McCauley, Marybeth; Cohen, Myron S; Cu... Journal: Clinical infectious diseases Issue: Volume 70:Number 2(2020) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. (19th March 2021) Authors: Marzinke, Mark A; Grinsztejn, Beatriz; Fogel, Jessica M; Piwowar-Manning, Estelle; Li, Maoji; Weng, Lei; McCauley, Marybeth; Cummings, Vanessa; Ahmed, Shahnaz; Haines, Casey D; Bushman, Lane R; Petropoulos, Christos; Persaud, Deborah; Adeyeye, Adeola; Kofron, Ryan; Rinehart, Alex; St Clair, Marty... Journal: Journal of infectious diseases Issue: Volume 224:Number 9(2021) Page Start: 1581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. (18th March 2022) Authors: Eshleman, Susan H; Fogel, Jessica M; Piwowar-Manning, Estelle; Chau, Gordon; Cummings, Vanessa; Agyei, Yaw; Richardson, Paul; Sullivan, Philip; Haines, Casey D; Bushman, Lane R; Petropoulos, Christos; Persaud, Deborah; Kofron, Ryan; Hendrix, Craig W; Anderson, Peter L; Farrior, Jennifer; Mellors,... Journal: Journal of infectious diseases Issue: Volume 225:Number 10(2022) Page Start: 1741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention. (14th October 2022) Authors: Eshleman, Susan H; Fogel, Jessica M; Halvas, Elias K; Piwowar-Manning, Estelle; Marzinke, Mark A; Kofron, Ryan; Wang, Zhe; Mellors, John; McCauley, Marybeth; Rinehart, Alex R; St Clair, Marty; Adeyeye, Adeola; Hinojosa, Juan C; Cabello, Robinson; Middelkoop, Keren; Hanscom, Brett; Cohen, Myron S;... Journal: Journal of infectious diseases Issue: Volume 226:Number 12(2022) Page Start: 2170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-acting injectable cabotegravir for the prevention of HIV infection. Issue 1 (January 2020) Authors: Clement, Meredith E.; Kofron, Ryan; Landovitz, Raphael J. Journal: Current opinion in HIV & AIDS Issue: Volume 15:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low incidence and prevalence of hepatitis C in two cohorts of HIV pre‐exposure prophylaxis adherence interventions in men who have sex with men in Southern California. Issue 7 (12th April 2022) Authors: Hassan, Adiba; Agustin, Harold Glenn San; Burke, Leah; Kofron, Ryan; Corado, Katya; Bolan, Robert; Landovitz, Raphael J.; Dubé, Michael P.; Morris, Sheldon R. Journal: Journal of viral hepatitis Issue: Volume 29:Issue 7(2022) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California. (15th December 2017) Authors: Landovitz, Raphael J.; Beymer, Matthew; Kofron, Ryan; Amico, Kathy Rivet; Psaros, Christina; Bushman, Lane; Anderson, Peter L.; Flynn, Risa; Lee, David P.; Bolan, Robert K.; Jordan, Wilbert C.; Tseng, Chi-Hong; Dierst-Davies, Rhodri; Rooney, Jim; Wohl, Amy Rock Journal: Journal of acquired immune deficiency syndromes Issue: Volume 76:Number 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States. (17th April 2021) Authors: Blumenthal, Jill; Jain, Sonia; He, Feng; Amico, K Rivet; Kofron, Ryan; Ellorin, Eric; Stockman, Jamila K; Psaros, Christina; Ntim, Gifty M; Chow, Karen; Anderson, Peter L; Haubrich, Richard; Corado, Katya; Moore, David J; Morris, Sheldon; Landovitz, Raphael J Journal: Clinical infectious diseases Issue: Volume 73:Number 7(2021) Page Start: 1149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. Issue 7 (July 2020) Authors: Landovitz, Raphael J; Li, Sue; Eron, Joseph J; Grinsztejn, Beatriz; Dawood, Halima; Liu, Albert Y; Magnus, Manya; Hosseinipour, Mina C; Panchia, Ravindre; Cottle, Leslie; Chau, Gordon; Richardson, Paul; Marzinke, Mark A; Eshleman, Susan H; Kofron, Ryan; Adeyeye, Adeola; Burns, David; Rinehart, Al... Journal: Lancet Issue: Volume 7:Issue 7(2020) Page Start: e472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The promise and pitfalls of long-acting injectable agents for HIV prevention. Issue 1 (January 2016) Authors: Landovitz, Raphael J.; Kofron, Ryan; McCauley, Marybeth Journal: Current opinion in HIV & AIDS Issue: Volume 11:Issue 1(2016:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗